Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders
- 26 January 2004
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 9 (4) , 406-416
- https://doi.org/10.1038/sj.mp.4001437
Abstract
We performed the oligonucleotide microarray analysis in bipolar disorder, major depression, schizophrenia, and control subjects using postmortem prefrontal cortices provided by the Stanley Foundation Brain Collection. By comparing the gene expression profiles of similar but distinctive mental disorders, we explored the uniqueness of bipolar disorder and its similarity to other mental disorders at the molecular level. Notably, most of the altered gene expressions in each disease were not shared by one another, suggesting the molecular distinctiveness of these mental disorders. We found a tendency of downregulation of the genes encoding receptor, channels or transporters, and upregulation of the genes encoding stress response proteins or molecular chaperons in bipolar disorder. Altered expressions in bipolar disorder shared by other mental disorders mainly consisted of upregulation of the genes encoding proteins for transcription or translation. The genes identified in this study would be useful for the understanding of the pathophysiology of bipolar disorder, as well as the common pathophysiological background in major mental disorders at the molecular level. In addition, we found the altered expression of LIM and HSPF1 both in the brains and lymphoblastoid cells in bipolar disorder. These genes may have pathophysiological importance and would be novel candidate genes for bipolar disorder.Keywords
This publication has 40 references indexed in Scilit:
- A PKCε–ENH–channel complex specifically modulates N-type Ca2+ channelsNature Neuroscience, 2003
- Polyglutamine protein aggregates are dynamicNature Cell Biology, 2002
- Genetic Variation in the 6p22.3 Gene DTNBP1, the Human Ortholog of the Mouse Dysbindin Gene, Is Associated with SchizophreniaAmerican Journal of Human Genetics, 2002
- Glutamatergic Mechanisms in SchizophreniaAnnual Review of Pharmacology and Toxicology, 2002
- PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizersMolecular Psychiatry, 2002
- The Action of Molecular Chaperones in the Early Secretory PathwayAnnual Review of Genetics, 2001
- Altered IMPA2 gene expression and calcium homeostasis in bipolar disorderMolecular Psychiatry, 2001
- Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorderMolecular Psychiatry, 2001
- Glutamate and its role in psychiatric illnessHuman Psychopharmacology: Clinical and Experimental, 2001
- The Stanley Foundation brain collection and Neuropathology ConsortiumSchizophrenia Research, 2000